Skip to main content

Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue--a new option for predictive biomarker assessment in breast cancer.

Müller BM, Kronenwett R, Hennig G, Euting H, Weber K, Bohmann K, Weichert W, Altmann G, Roth C, Winzer KJ, Kristiansen G, Petry C, Dietel M, Denkert C

Publication: Diagn Mol Pathol (2011) • Vol 20 • Page 1-10PMID: 21326033View on PubMed

Purpose

The purpose of this paper was to determine the effects of storage, amplicon length and targeted transcript on the amplification of RNA extracted from formalin-fixed paraffin-embedded (FFPE) breast tumors using a new fully automated xylene free RNA extraction method.

Conclusion

Fragments of glucose-6-phosphate dehydrogenase (G6PDH) that were up to 151 bp long were successfully amplified, but amplification of longer fragments was not usually successful. During the first 10 years of storage, the average RNA yield decreased and cycle threshold (CT) values increased, but no further storage effects were seen. A high degree of concordance was observed between qRT-PCR and immunohistochemistry (IHC) for estrogen receptor alpha (ESR1), progesterone receptor (PGR), and epidermal growth factor receptor 2 (HER2). Different sections from the same tumor showed similar CT values for all three biomarkers, regardless of storage duration.

Studies (1)

Purpose

The purpose of this study was to determine the effects of storage, amplicon length, and targeted transcript on real-time RT-PCR success from single sections of FFPE breast tumors. The authors also compared real-time RT-PCR and IHC staining results.

Summary of Findings

Amplifications of the 67 bp and 151 bp fragments of G6PDH were successful in 100% and 99% of specimens, respectively. In contrast, amplification of the 242 bp fragment was successful in only 1.8% of specimens and amplification of larger fragments was not possible. RNA average yield decreased from 2.9 ug to 1.4 ug per section and the RPL37A CT increased from 22 to 25 over the first 10 years of storage, but no further storage effects were seen. A high degree of concordance was observed between qRT-PCR and IHC for ESR1 (98.4%), PGR (84.4%), and HER2 (89.8%). Different sections from the same tumor showed similar CT values for all three biomarkers, regardless of storage duration.
  • Biospecimens

    TissueBreast
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    RNAReal-time qRT-PCR
    RNART-PCR
    ProteinImmunohistochemistry
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    StorageStorage duration
    11-13 y
    14-16 y
    17-21 y
    2-5 y
    <1 y
    RT-PCR SpecificLength of gene fragment
    151 bp
    242 bp
    379 bp
    453 bp
    67 bp
    RT-PCR SpecificTargeted nucleic acid
    Glucose-6-phosphate dehydrogenase
    Real-time qRT-PCR SpecificTargeted nucleic acid
    ESR1
    HER2
    PGR
    RPL37a
    Immunohistochemistry SpecificTargeted peptide/protein
    ESR
    HER2
    PGR